Welcome to the News Room

Pugatch Consilium at the New Delhi conference on Expanding Healthcare Access in India

Posted by:

Last thursday January 14, 2016, Prof Meir Pugatch spoke at the groundbreaking conference entitled “Growing the Innovative Bio-pharmaceutical Industry and Expanding Healthcare Access in India” in New Delhi convened by the The U.S.-India Business Council (USIBC) in partnership with the Department of Industrial Policy and Promotion (DIPP) and the Investment and Technology Promotion Division (ITP) of the Ministry of External Affairs. During the session, Prof Pugatch presented the findings of one of Pugatch Consilium’s latest studies on India, highlighting how the country stands to increase its number of new clinical trials per year from around 170 to above 800 and add over 600 million dollars in direct monetary transfers and indirect economic gains. Although already being a global leader in pharmaceuticals, India has the potential to grow and increase R&D intensity domestically while also attracting investment from outside the country by focusing on key policy areas in clinical research.

More information on the conference can be found here: ET Health World

The study ‘Quantifying the Economic Gains of Strengthening India’s Clinical Research Policy Environment’ and its results can be found on our Research & Analysis Page.


About the Author:

David’s focus is policy and economic analysis related to innovation, health care, pharmaceuticals, tax and intellectual property. He has wide experience in quantitative research methods including index-building and data sampling and is the author of a number of both academic and commissioned publications. David’s knowledge spans from North America and Europe to the BRIC economies, and he speaks fluent Swedish. Prior to his work with Pugatch Consilium, David was with Deloitte LLP where he worked on a broad range of UK and international tax compliance and advisory projects. David holds a Master of Studies and DPhil (PhD) from Oxford University.
  Related Posts
  • No related posts found.